Numerous clinical trials have been performed to identify the optimal therapeutic range for various indications in patients receiving warfarin. Other studies have identified risk factors for hemorrhage and thromboembolism to decrease the risk of these complications. A more consistent approach, using guidelines presented in this article, toward initiation, monitoring, and reversal of anticoagulation should further decrease the incidence of complications.
|Original language||English (US)|
|Number of pages||8|
|Journal||Seminars in Vascular Surgery|
|State||Published - Dec 20 1996|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine